August 20, 2014
A California federal judge on Tuesday dismissed for the second time a suit accusing Novartis Pharmaceuticals Corp.'s bone drug Zometa of causing jaw injuries, ruling the plaintiff could not use Maryland law to skirt a California statute of limitations on the case.